Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury

Detalhes bibliográficos
Autor(a) principal: Souza, Daniele G.
Data de Publicação: 2003
Outros Autores: Pinho, Vanessa, Pesquero, Jorge L., Lomez, Eliane S., Poole, Steve, Juliano, Luiz [UNIFESP], Correa Junior, Ary, Castro, M Salete D, Teixeira, Mauro M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1038/sj.bjp.0705200
http://repositorio.unifesp.br/handle/11600/27215
Resumo: 1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury.
id UFSP_79e9bec64ed94c67e5d86f473f830582
oai_identifier_str oai:repositorio.unifesp.br/:11600/27215
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injuryischemia and reperfusioncytokinesTNF-alphabradykininneutrophilsshock1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury.Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, BrazilUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Farmacol, Belo Horizonte, MG, BrazilUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilNatl Inst Biol Stand & Controls, Div Endocrinol, Potters Bar EN6 3QG, Herts, EnglandUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilWeb of ScienceNature Publishing GroupUniversidade Federal de Minas Gerais (UFMG)Universidade Federal de São Paulo (UNIFESP)Natl Inst Biol Stand & ControlsSouza, Daniele G.Pinho, VanessaPesquero, Jorge L.Lomez, Eliane S.Poole, SteveJuliano, Luiz [UNIFESP]Correa Junior, AryCastro, M Salete DTeixeira, Mauro M.2016-01-24T12:33:48Z2016-01-24T12:33:48Z2003-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion129-139http://dx.doi.org/10.1038/sj.bjp.0705200British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003.10.1038/sj.bjp.07052000007-1188http://repositorio.unifesp.br/handle/11600/27215WOS:000183125500015engBritish Journal of Pharmacologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:48Zoai:repositorio.unifesp.br/:11600/27215Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:48Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
title Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
spellingShingle Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
Souza, Daniele G.
ischemia and reperfusion
cytokines
TNF-alpha
bradykinin
neutrophils
shock
title_short Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
title_full Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
title_fullStr Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
title_full_unstemmed Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
title_sort Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
author Souza, Daniele G.
author_facet Souza, Daniele G.
Pinho, Vanessa
Pesquero, Jorge L.
Lomez, Eliane S.
Poole, Steve
Juliano, Luiz [UNIFESP]
Correa Junior, Ary
Castro, M Salete D
Teixeira, Mauro M.
author_role author
author2 Pinho, Vanessa
Pesquero, Jorge L.
Lomez, Eliane S.
Poole, Steve
Juliano, Luiz [UNIFESP]
Correa Junior, Ary
Castro, M Salete D
Teixeira, Mauro M.
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de Minas Gerais (UFMG)
Universidade Federal de São Paulo (UNIFESP)
Natl Inst Biol Stand & Controls
dc.contributor.author.fl_str_mv Souza, Daniele G.
Pinho, Vanessa
Pesquero, Jorge L.
Lomez, Eliane S.
Poole, Steve
Juliano, Luiz [UNIFESP]
Correa Junior, Ary
Castro, M Salete D
Teixeira, Mauro M.
dc.subject.por.fl_str_mv ischemia and reperfusion
cytokines
TNF-alpha
bradykinin
neutrophils
shock
topic ischemia and reperfusion
cytokines
TNF-alpha
bradykinin
neutrophils
shock
description 1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury.
publishDate 2003
dc.date.none.fl_str_mv 2003-05-01
2016-01-24T12:33:48Z
2016-01-24T12:33:48Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1038/sj.bjp.0705200
British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003.
10.1038/sj.bjp.0705200
0007-1188
http://repositorio.unifesp.br/handle/11600/27215
WOS:000183125500015
url http://dx.doi.org/10.1038/sj.bjp.0705200
http://repositorio.unifesp.br/handle/11600/27215
identifier_str_mv British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003.
10.1038/sj.bjp.0705200
0007-1188
WOS:000183125500015
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv British Journal of Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 129-139
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268384654655488